TRAV20

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, TRAV20 mutation is significantly associated with the immune_cell of many other genes, with 3 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible TRAV20-associated genes across cancer lineages are CD4+ Tem, CD8+ Tcm, and CD8+ Tem. Each is linked with TRAV20 in more than 1 cancer types. Because this analysis shows association rather than direction, both TRAV20-to-partner and partner-to-TRAV20 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TRAV20→partner) and Y-score (partner→TRAV20) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECCD4+ Tem →+0.017+3.081.026.03931
UCECCD8+ Tcm →+0.040+2.935.003.04631
UCECCD8+ Tem →+0.007+5.744<.001.02231
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Exploration